Legend Biotech Corporation (LEGN) reported Loss for third quarter of -$39.69 million
The company's earnings came in at -$39.69 million, or -$0.11 per share. This compares with -$125.32 million, or -$0.34 per share, last year.
Excluding items, Legend Biotech Corporation reported adjusted earnings of -$18.78 million or -$0.05 per share for the period.
The company's revenue for the period rose 70.0% to $272.33 million from $160.21 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings: -$39.69 Mln. vs. -$125.32 Mln. last year.-EPS: -$0.11 vs. -$0.34 last year.-Revenue: $272.33 Mln vs. $160.21 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.